Nigeria arrests Pfizer director

Pharma directors on the lam. That's not a statement one expects to hear, but today in Nigeria, it's true. As part of its infamous prosecution of Pfizer, a Nigerian court has issued warrants for eight Pfizer officials. One, a former medical director, has already been arrested. Others, including the former managing director Ngozi Edozien, are on the run.

You'll recall that Pfizer is embroiled in defending itself against civil and criminal charges stemming from a meningitis drug trial. Some trial participants died and others suffered permanent disability. The government and some patients say Pfizer was at fault, and that the company misled them about its research. Pfizer denies wrongdoing, saying that the disease itself could have caused the injuries and deaths.

The scene at Pfizer's Nigerian HQ was bizarre yesterday, with entrances padlocked and managers missing. It's a reminder of the hazards of doing business globally. Presumably, Pfizer's reps in Nigeria aren't thinking so philosophically about it right now. 

- read the report at All Africa

Related Articles:
Pfizer-Nigeria lawsuit talks fall apart. Report
Nigeria calls Pfizer execs to trial. Report
Pfizer seeks dismissal of Nigeria lawsuit. Report
Trial deaths spur criminal charges against Pfizer. Report
Pfizer 'exploited' children in African trial. Report

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

In its quest to become the dominant SGLT2 diabetes med for heart failure, Jardiance is touting DPP-4 inhibitor-topping data to support its case.

Despite having lost some of its novelty, AZ's Brilinta is touting bleeding data over aspirin that could be a big break in acute coronary syndrome.